InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,321.41
(
0.25%
)
US TECH 100
18,243.60
(
0.26%
)
Dow Jones
39,872.99
(
0.17%
)
Brent Oil
82.13
(
-0.39%
)
Bitcoin
70,024.77
(
-0.15%
)
Post# of 402891
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BonelessCat

Send PM Follow Ignore
Followers 261
Posts 19732
Boards Moderated 0
Alias Born 10/03/2004

BonelessCat

Re: loanranger post# 248463

Monday, 11/12/2018 8:47:26 AM

Monday, November 12, 2018 8:47:26 AM

Post# of 402891
It is an end-of-Phase meeting so, yes, a Phase 2/3 could be considered a successful outcome, but an FDA requirement for a second phase 2 would be an unseccessful meeting.

I don’t understand the confusion over an end-of-Phase meeting. What that means should be clear to any investor in any biopharma company.

* Never borrow to invest.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IPIX News
More IPIX News
InvestorsHub NewsWire

"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Start posting your company's news
Only $200 per official company press release!